Detailed answers about BELLADERM LASER EQUIPMENTS LIMITED, including incorporation, status, business activity, and accounts information.
When was BELLADERM LASER EQUIPMENTS LIMITED founded?
BELLADERM LASER EQUIPMENTS LIMITED was officially incorporated on 21 September 2026 and is registered under company number 17471469. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BELLADERM LASER EQUIPMENTS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BELLADERM LASER EQUIPMENTS LIMITED?
BELLADERM LASER EQUIPMENTS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BELLADERM LASER EQUIPMENTS LIMITED do?
BELLADERM LASER EQUIPMENTS LIMITED operates in the following sectors: 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 47789 - Other retail sale of new goods in specialised stores (not commercial art galleries and opticians). These SIC codes provide insight into the company's business activities and industry focus.
What is BELLADERM LASER EQUIPMENTS LIMITED's registered address?
The registered office address of BELLADERM LASER EQUIPMENTS LIMITED is 168 Newport Road, Aldershot, England, GU12 4PZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is BELLADERM LASER EQUIPMENTS LIMITED financially stable?
Financial accounts for BELLADERM LASER EQUIPMENTS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.